Alto Pharmacy Stock

alto.comDigital HealthFounded: 2015Funding to Date: $354.19MM

Alto the developer of a telehealth pharmacy focused on helping people live healthier by making the prescription experience easier, more supportive, and more affordable.

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for Alto Pharmacy, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Alto Pharmacy.

Register Today
Register for Details

For more details on financing and valuation for Alto Pharmacy, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Alto Pharmacy investors also invested in these private companies

Team

Management Team

Mattieu Gamache-Asselin
Co-Founder & Chief Executive Officer
Jamie Karraker
Co-Founder & Chief Technology Officer
Kevin Burns
President & Chief Operations Officer
Jared Fix
Chief Commercial Officer

Board Members

Josh Breinlinger
Jackson Square Ventures

Other companies like Alto Pharmacy in the Digital Health sector

Sector
Last Round Est. Valuation
$1.6B
Sector
Last Round Est. Valuation
$2.69B
Sector
Last Round Est. Valuation
$5.25B
Sector
Last Round Est. Valuation
$3.77B
Sector
Last Round Est. Valuation
$2B
Sector
Last Round Est. Valuation
$4.8B
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$2.63B
Sector
Last Round Est. Valuation
$6.05B

News

SoftBank's huge investment in the pharmacy startup likely marks the beginning of its foray into US consumer healthcare.
Alto, a pharmacy tech company, announced that it has raised $50 million in Series C funding led by Zola Global and Greenoaks Capital.
Online pharmacy Alto has raised $50 million in a series C round of funding from Greenoaks Capital, Zola Capital, and Jackson Square Ventures.